Patent details

Basic Information

Publication number:

91902

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP019377647

Legal Status:

Active

Application number:

91902

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/11/694/001-002 - NULOJIX -Bélatacept

Marketing Authorization Type:

Marketing Authorization Date:

17/06/2011

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

16/11/2011

First Marketing Authorization date:

17/06/2011

Grant date:

16/01/2012

Activation date:

23/05/2021

Publication date:

16/01/2012

Lapsed date:

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

23/05/2026

SPC Extension Expiration:

23/05/2026

Rejection date:

Withdrawal date:

Owner

From:

16/11/2011

 

 

Name:

Bristol-Myers Squibb Co.

Address:

P.O. Box 4000, Lawrenceville-Princeton Road, Princeton, NJ 08543-4000, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

16/11/2011

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

PEACH Robert, J.

Address:

United States (US)

2

Name:

NAEMURA Joseph, R.

Address:

United States (US)

3

Name:

BAJORATH Jurgen

Address:

United States (US)

4

Name:

LINSLEY Peter, S.

Address:

United States (US)

Publication

Bulletin

Bulletin Heading:

SPC3

Bulletin edition number:

2021/07

Publication date:

03/06/2021

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

16/05/2025

Last Annual Fee Paid Number:

25

Last Annual Fee Paid Amount:

450 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages